Below are the most recent publications written about "Collagen Type II" by people in Profiles.
-
Gomez J, Rice SM, Makhamreh MM, Al-Kouatly HB. Pregnancy management in a patient with stickler syndrome. Mol Genet Genomic Med. 2020 08; 8(8):e1311.
-
Savarirayan R, Bompadre V, Bober MB, Cho TJ, Goldberg MJ, Hoover-Fong J, Irving M, Kamps SE, Mackenzie WG, Raggio C, Spencer SS, White KK. Best practice guidelines regarding diagnosis and management of patients with type II collagen disorders. Genet Med. 2019 09; 21(9):2070-2080.
-
Fertala J, Arita M, Steplewski A, Arnold WV, Fertala A. Epiphyseal growth plate architecture is unaffected by early postnatal activation of the expression of R992C collagen II mutant. Bone. 2018 07; 112:42-50.
-
Bundens G, Buckley A, Milton L, Behling K, Chmielewski S, Cho E, Lozano-Torres X, Selim A, Lackman R, George-Weinstein M, Miller L, D'Angelo M. Measuring clinically relevant endpoints in a serum-free, three-dimensional, primary cell culture system of human osteoarthritic articular chondrocytes. Exp Cell Res. 2017 08 15; 357(2):310-319.
-
Arita M, Fertala J, Hou C, Kostas J, Steplewski A, Fertala A. Prospects and limitations of improving skeletal growth in a mouse model of spondyloepiphyseal dysplasia caused by R992C (p.R1192C) substitution in collagen II. PLoS One. 2017; 12(2):e0172068.
-
Rizzo P, Pitocco D, Zaccardi F, Di Stasio E, Strollo R, Rizzi A, Scavone G, Costantini F, Galli M, Tinelli G, Flex A, Caputo S, Pozzilli P, Landolfi R, Ghirlanda G, Nissim A. Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus. Diabetes Metab Res Rev. 2017 02; 33(2).
-
Cecen B, Kozaci LD, Yuksel M, Ustun O, Ergur BU, Havitcioglu H. Biocompatibility and biomechanical characteristics of loofah based scaffolds combined with hydroxyapatite, cellulose, poly-l-lactic acid with chondrocyte-like cells. Mater Sci Eng C Mater Biol Appl. 2016 Dec 01; 69:437-46.
-
Arita M, Fertala J, Hou C, Steplewski A, Fertala A. Mechanisms of aberrant organization of growth plates in conditional transgenic mouse model of spondyloepiphyseal dysplasia associated with the R992C substitution in collagen II. Am J Pathol. 2015 Jan; 185(1):214-29.
-
Brescia AC, Simonds MM, McCahan SM, Fawcett PT, Rose CD. The role of transforming growth factor ? signaling in fibroblast-like synoviocytes from patients with oligoarticular juvenile idiopathic arthritis: dysregulation of transforming growth factor ? signaling, including overexpression of bone morphogenetic protein 4, may lead to a chondrocyte phenotype and may contribute to bony hypertrophy. Arthritis Rheumatol. 2014 May; 66(5):1352-62.
-
Takahashi T, Katsuta S, Tamura Y, Nagase N, Suzuki K, Nomura M, Tomatsu S, Miyamoto K, Kobayashi S. Bone-targeting endogenous secretory receptor for advanced glycation end products rescues rheumatoid arthritis. Mol Med. 2013 Jul 24; 19:183-94.